Weight Gain Common in Young Women After Breast Reduction Surgery
By Lori Solomon HealthDay Reporter
THURSDAY, Feb. 6, 2025 -- Many young women gain weight in the years after breast reduction surgery, according to a study published online in the February issue of Plastic and Reconstructive Surgery.
William N. Doyle Jr., from the University of South Florida Morsani College of Medicine in Tampa, and colleagues examined change in weight and body mass index (BMI) in adolescent women (aged younger than 21 years) following reduction mammaplasty. The analysis included 56 patients with weight measurements during a median 46.0 months of follow-up.
The researchers found that only 22 patients (39.3 percent) experienced a decrease in BMI at final follow-up compared with baseline. At two-, three-, and five-year visits and at final postoperative follow-up visits, patients classified as having a healthy weight preoperatively (BMI, 18.5 to 24.9 kg/m2) experienced a significant increase in BMI versus baseline. In contrast, patients classified as having overweight (BMI, 25.0 to 29.99 kg/m2) or obesity (≥30 kg/m2) did not experience significant BMI change at final postoperative follow-up.
"BMI and weight trended upward postoperatively regardless of BMI classification," the authors write. "Reduction mammaplasty alone is not sufficient to stimulate weight loss. Healthy lifestyle changes should be encouraged to help prevent weight gain in adolescent women following reduction mammaplasty."
One author disclosed receiving royalties for textbook authorship from Thieme Publishing.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Few Adolescents With Obesity Prescribed Obesity Medications
FRIDAY, June 13, 2025 -- Despite an increase in the prevalence of prescribing, only 0.5 percent of U.S. adolescents with obesity were prescribed an obesity medication in 2023...
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower...
Adherence to Healthy Diet Improves Cardiometabolic Risk, Even Without Weight Loss
WEDNESDAY, June 11, 2025 -- A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.